LEXINGTON BIOMEDICAL RESEARCH (EIN 611222684) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1992

Legal Domicile

Phone

8592334511

Tax Period

2023-01-01 to 2023-12-31

LEXINGTON BIOMEDICAL RESEARCH, founded in 1992, is a small nonprofit in the Health Care sector that reported $643K in total revenue in fiscal year 2023. Revenue surged 53% from the prior year, signaling strong growth momentum. The organization ran a surplus of $156K, a strong 24% operating margin.

Mission

ASSIST IN RESEARCH AND EDUCATIONAL ACTIVITIES IN ACCORDANCE WITH FEDERAL RULES AND REGULATIONS IN ASSOCIATION WITH THE LEXINGTON VA MEDICAL CENTER

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $561,500

Program Service Revenue $81,258

Investment Income $0

Other Revenue $0

TOTAL REVENUE $642,758

Expense Breakdown

Grants Paid $0

Salaries & Benefits $261,112

Fundraising Expenses $0

Program Expenses $438,501

Other Expenses $225,593

TOTAL EXPENSES $486,705

Year-over-Year Comparison

	2023	2022	Change
Revenue	$642,758	$420,484	+0.5%
Expenses	$486,705	$486,278	+0.0%
Net Income	$156,053	$-65,794	-3.4%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
VANESSA MCQUEEN	N/A	35.00		$66,136	$0	$66,136
JUDY F GLASS	ADMIN	40.00		$50,186	$0	$50,186
ALYSSA RODGERS	N/A	40.00		$33,144	$0	$33,144
MORGAN BISHOP	N/A	24.00		$32,131	$0	$32,131
CAROLYN BROWN	EXEC DIR	17.00		$31,896	$0	$31,896
JULIA SPIRES	N/A	25.00		$10,899	$0	$10,899
DAVID L WELLS	President	0.00	Director	$0	$0	$0
RUSSEL ARMSTEAD	Director	0.00	Director	$0	$0	$0
DENNIS KAROUNOS	Director	0.00	Director	$0	$0	$0
REBECCA DUTCH	Director	0.00	Director	$0	$0	$0
PEDRO VERA	Treasurer	0.00	Director	$0	$0	$0
TUYEN TRAN	Director	0.00	Director	$0	$0	$0
LYN COVERT	Director	0.00	Director	$0	$0	$0
MORRIS CHAMNESS	Director	0.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2023	$642,758	$486,705	$442,399	$156,053
2021	$390,300	$423,892	$352,140	$-33,592
2020	$467,074	$491,973	$385,732	$-24,899
2019	$315,455	$439,236	$410,099	$-123,781
2018	$373,562	$415,825	$532,797	$-42,263

LEXINGTON BIOMEDICAL RESEARCH